Smoking and obesity combined may greatly accelerate multiple sclerosis progression, study finds

New Research Highlights the Amplified Risk of Disease Progression and Cognitive Decline

A recent study has found that smoking and obesity, two well-known risk factors for multiple sclerosis (MS) progression, may have a compounding effect when present together. Among 3,336 individuals with MS, researchers observed that those who both smoked and were living with obesity faced a significantly increased risk of disease progression and cognitive decline compared to those who had neither risk factor. These findings highlight the importance of lifestyle interventions in managing MS and potentially slowing its progression.

Background: The Known Risks of Smoking and Obesity in MS

Previous studies have established that both smoking and obesity independently contribute to the progression of MS. Individuals with MS who smoke have been found to experience faster deterioration in physical and cognitive functions, while obesity has been linked to increased inflammation and greater disability over time.

Outside of MS, research in conditions such as heart disease and diabetes has shown that smoking and obesity do not merely add to the risk of poor health outcomes—they interact in ways that amplify those risks beyond what would be expected from either factor alone. However, until now, limited research has explored whether this type of interaction also occurs in MS. Understanding whether these risk factors reinforce each other in MS progression could be critical in developing more effective prevention and management strategies.

Study Overview: Investigating the Combined Effects of Smoking and Obesity

A team of researchers from the Karolinska Institute in Sweden conducted an extensive review of medical records from 3,336 individuals with MS. Their aim was to determine whether smoking and obesity interact to worsen disease progression and cognitive decline.

To measure disease progression, the researchers used the Expanded Disability Status Scale (EDSS), a standardised system that evaluates disability levels in people with MS. The EDSS assesses a range of neurological functions, including walking ability, muscle strength, vision, and cognitive performance.

Key Findings: A Significant Interaction Between Smoking and Obesity

Consistent with previous research, the study confirmed that both smoking and obesity independently increased the risk of faster disease progression. Smoking was also linked to a greater likelihood of cognitive impairment. However, the most striking finding was that the combination of these two risk factors led to an even greater acceleration of MS progression and cognitive decline.

When comparing different groups of people with MS:

• Non-obese smokers had a 21% higher risk of reaching EDSS level 4 (which signifies significant disability but preserved walking ability) compared to non-smokers who were not obese.
• Individuals who were obese but did not smoke had a 33% higher risk of reaching EDSS 4.
• However, individuals who both smoked and were living with obesity had an 86% higher risk of reaching EDSS 4, demonstrating that these two factors together substantially increase the likelihood of disability progression.

In addition to physical disability, the study found that smoking and obesity also interacted to exacerbate cognitive decline, further impairing memory, concentration, and problem-solving abilities in individuals with MS.

Implications: The Importance of Modifiable Risk Factors

The findings of this study are particularly significant because both smoking and obesity are modifiable risk factors. Unlike genetic predisposition or other non-preventable aspects of MS, these behaviours can be changed, offering individuals the opportunity to potentially slow their disease progression.

“This study suggests that dropping even one unhealthy habit could potentially lead to a substantially reduced risk of unfavourable disease outcomes,” the researchers noted.

For individuals with MS, quitting smoking and achieving a healthy weight could have far-reaching benefits, not only in terms of reducing the risk of disability but also improving overall well-being. There are numerous resources available to support these lifestyle changes, including smoking cessation programmes, dietary counselling, and physical activity interventions tailored to those with MS.

Understanding Multiple Sclerosis

Multiple sclerosis is a chronic and unpredictable condition that affects the central nervous system. The disease occurs when the immune system mistakenly attacks the protective covering of nerve fibres, leading to inflammation and damage that disrupts communication between the brain and the rest of the body.

Symptoms of MS vary widely among individuals and may include:

• Fatigue – Debilitating tiredness that affects daily activities.
• Mobility Challenges – Weakness, muscle stiffness, and difficulties with balance and coordination.
• Cognitive Changes – Issues with memory, concentration, and problem-solving.
• Vision Problems – Blurred or double vision, or even vision loss in severe cases.

Currently, there is no cure for MS, but early diagnosis and treatment can help slow the disease’s progression and improve quality of life. Researchers continue to make significant progress towards developing more effective therapies and, ultimately, achieving a future free from MS.

Conclusion: A Call for Awareness and Action

This study underscores the importance of addressing modifiable lifestyle factors in the management of MS. While the condition itself remains incurable, interventions such as smoking cessation and weight management can make a meaningful difference in slowing disease progression and reducing disability risk.

Healthcare professionals and individuals with MS alike should take note of these findings and explore available support options for making healthier lifestyle choices. The research serves as a powerful reminder that even small changes can contribute to better long-term outcomes in the management of multiple sclerosis.